Yes, variants like G1793A (rs2274976) can also significantly decrease enzyme function, while others, such as rs9651118 and rs13306560, are associated with positive health outcomes like lower blood pressure or reduced risk of certain diseases
Aging 2 , 11121129 (2022)
The stated rationale was accurate as far as it went: insufficient safety data, immunogenicity concerns, manufacturing quality issues
Again, there were no new diagnoses within 1 year or during the L-carnitine supplementation, and medications were unchanged for at least 4 months before and during the study
GLP-1 drugs, formally called glucagon-like peptide-1 receptor agonists, are incretin-based therapies that activate the GLP-1 receptor
GLP-1RAs can cross the bloodbrain barrier and activate brain GLP-1 receptors, leading to neuroprotection by improving insulin signaling, reducing tau hyperphosphorylation, and enhancing cognitive function in diabetic and aging models